Publication: Hypermethylation of suppressor of cytokine signaling 1 in hepatocellular carcinoma patients
Issued Date
2012-01-01
Resource Type
ISSN
2476762X
15137368
15137368
Other identifier(s)
2-s2.0-84873628694
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Asian Pacific Journal of Cancer Prevention. Vol.13, No.7 (2012), 3489-3493
Suggested Citation
Pensri Saelee, Ubol Chuensumran, Sopit Wongkham, Sunanta Chariyalertsak, Danai Tiwawech, Songsak Petmitr Hypermethylation of suppressor of cytokine signaling 1 in hepatocellular carcinoma patients. Asian Pacific Journal of Cancer Prevention. Vol.13, No.7 (2012), 3489-3493. doi:10.7314/APJCP.2012.13.7.3489 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/13859
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Hypermethylation of suppressor of cytokine signaling 1 in hepatocellular carcinoma patients
Other Contributor(s)
Abstract
Hepatocellular carcinoma (HCC), the most common primary hepatic tumor, is highly prevalent in the Asia-Pacific region, including Thailand. Many genetic and epigenetic alterations in HCC have been elucidated. The aim of this study was to determine whether aberrant methylation of the suppressor of cytokine signaling 1 gene (SOCS1) occurs in HCCs. Methylation specific-PCR assays were performed to identify the methylation status of SOCS1 in 29 tumors and their corresponding normal liver tissues. An abnormal methylation status was detected in 17 (59%), with a higher prevalence of aberrant SOCS1 methylation significantly correlating with HCC treated without chemotherapy (OR=0.04, 95%CI=0.01-0.31; P=0.001). This study suggests that epigenetic aberrant SOCS1 methylation may be a predictive marker for HCC patients.